ALC vs BAX vs HSIC

For growth investors, Baxter International Inc.

(BAX) is the stronger pick with 5. 7% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Alcon Inc. (ALC) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 6x versus Alcon Inc. at 32. 3x. On forward P/E, Baxter International Inc. is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Alcon Inc.

(ALC) delivered a total return of -6. 7%, compared to -74. 3% for Baxter International Inc. (BAX). Over 10 years, the gap is even starker: ALC returned +13. 0% versus BAX's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 73β versus Baxter International Inc. 's 1. 37β — meaning BAX is approximately 87% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Alcon Inc. (ALC) carries a lower debt/equity ratio of 24% versus 164% for Baxter International Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Baxter International Inc.

(BAX) is pulling ahead at 5. 7% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: Henry Schein, Inc. grew EPS 7. 2% year-over-year, compared to -37. 8% for Baxter International Inc.. Over a 3-year CAGR, ALC leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alcon Inc.

(ALC) is the more profitable company, earning 9. 4% net margin versus -8. 5% for Baxter International Inc. — meaning it keeps 9. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALC leads at 13. 1% versus -2. 7% for BAX. At the gross margin level — before operating expenses — ALC leads at 55. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Baxter International Inc.

(BAX) trades at 9. 2x forward P/E versus 18. 8x for Alcon Inc. — 9. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALC: 46. 2% to $93. 36.

In this comparison, BAX (3.

9% yield), ALC (0. 5% yield) pay a dividend. HSIC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Alcon Inc.

(ALC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 80), 0. 5% yield). Both have compounded well over 10 years (ALC: +13. 0%, BAX: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ALC is a mid-cap quality compounder stock; BAX is a small-cap income-oriented stock; HSIC is a small-cap quality compounder stock. ALC, BAX pay a dividend while HSIC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.